electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th

Rhea-AI Summary

electroCore, Inc. (NASDAQ: ECOR) will report its financial results for Q3 2021 on November 4, 2021, following the market close. A conference call will be held at 4:30 PM ET to discuss the results. The company focuses on non-invasive vagus nerve stimulation therapies aimed at treating various neurological conditions including migraines and cluster headaches. With a commercial-stage product line, electroCore aims to improve patient outcomes.

Positive

• Focused on innovative non-invasive treatments for neurological conditions.
• Upcoming Q3 earnings report may provide insights into financial health.

Negative

• None.

ROCKAWAY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third quarter ended September 30, 2021 after the close of the market on Thursday, November 4, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.

Thursday, November 4, 2021, 4:30pm Eastern Time
Domestic: 877-269-7756
International: 201-689-7817
Conference ID: 13722407
Webcast: electroCore 3Q21 Earnings Webcast

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit www.electrocore.com.

FAQ

When will electroCore announce its Q3 2021 financial results?

electroCore will announce its Q3 2021 financial results on November 4, 2021.

What time is the electroCore Q3 earnings conference call?

The conference call will take place at 4:30 PM ET on November 4, 2021.

What conditions does electroCore's therapy target?

electroCore's therapy targets conditions like migraines, cluster headaches, and other related neurological disorders.

What is the ticker symbol for electroCore?

The ticker symbol for electroCore is ECOR.